Table 7.
The serum anti-oxidative parameters after indicated treatments1
| Medicated groups | Vaccinated groups | P value | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Met2 concentrations: | 0.45% | 0.56% | 0.68% | 0.45% | 0.56% | 0.68% | Anticoccidial program | Met levels | Anticoccidial program × Met levels |
| GPx (U/mL) | 1285.26 ± 172.80b | 1392.71 ± 194.74a | 1321.81 ± 186.24ab | 1240.43 ± 157.82b | 1266.49 ± 160.72b | 1265.93 ± 161.22b | 0.042 | 0.038 | 0.021 |
| MDA (nmol/mL) | 6.93 ± 0.72e | 8.62 ± 0.89c | 10.64 ± 1.11a | 7.74 ± 0.99d | 8.66 ± 1.19c | 9.40 ± 1.34b | 0.102 | 0.015 | 0.207 |
| T-AOC (mmol Trolox) | 9.55 ± 1.07b | 10.36 ± 1.96a | 9.85 ± 1.53ab | 8.46 ± 0.93c | 8.77 ± 1.01bc | 8.79 ± 1.17bc | 0.023 | 0.032 | 0.035 |
1An anticoccidial drug (narasin, 60 mg/kg diet) was added to diets in medicated groups, and an anticoccidial 7-valent live vaccine was inoculated in vaccinated groups
2Met methionine, GPx glutathione peroxidase, MDA malondialdehyde, T-AOC total antioxidant capacity
a,b,c,d,eThe data of the same row not sharing a lowercase letter differ (P < 0.05, n = 30)